ANI Pharmaceuticals | ANIP - Trade Debtors


ANI Pharmaceuticals reported $252.62M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
ANI Pharmaceuticals USD 252.62M 26.96M Sep/2025
Assertio Holdings USD 39.91M 2.7M Jun/2024
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Hikma Pharmaceutical USD 1.11B 133M Jun/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Nektar Therapeutics USD 0 2.9M Sep/2024
Novartis USD 8.98B 192M Sep/2025
Omeros USD 8.08M 440K Jun/2024
Perrigo USD 644.4M 62.2M Sep/2025
Sun Pharmaceuticals INR 157.04B 26.1B Sep/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025